CMS reports $1.6 billion in potentially improper Medicare lab payments stopped
CMS says it stopped more than $1.6 billion in potentially improper Medicare lab payments through revocations, suspensions, referrals and recoveries.
CMS says it stopped more than $1.6 billion in potentially improper Medicare lab payments through revocations, suspensions, referrals and recoveries.
CMS says 50 high-risk Medicaid providers were tied to $203.3 million in payments subject to federal or state action, not necessarily proven fraud or recovered cash.
The Justice Department says 455 defendants, including 90 doctors and other licensed professionals, were charged in a national operation involving alleged false claims and opioid-abuse schemes.
Federal health officials paused more than $1 billion in Medicaid payments to California and Minnesota while reviewing high-risk claims, including California in-home-care claims.
The Justice Department says the coordinated action involved more than $6.5 billion in alleged false claims and opioid-abuse schemes across 56 federal districts.
Khalid Ahmed Satary was apprehended July 20 and transferred to U.S. custody in a case alleging medically unnecessary genetic tests and more than $547 million in Medicare claims or losses.
On July 17, 2026, DOJ’s Southern District of Mississippi filed civil complaints alleging CSA recordkeeping failures at a Brookhaven pharmacy and a Missouri clinic.
DOJ says EyePoint will pay $4,657,463.18 to resolve False Claims Act allegations tied to DEXYCU kickbacks (2019–Mar. 1, 2023) and a five-year HHS-OIG CIA.
United States Federal Policy and Agency Actions – On June 23, 2026, DOJ announced charges against 455 defendants, alleging $6.5B+ in false claims for fraud and opioids.
Federal prosecutors charged 13 North Texas defendants in seven cases, with most in the Dallas division, as part of a June 23 fraud sweep.
DOJ says its 2026 National Health Care Fraud Takedown charged 455 defendants tied to more than $6.5B in alleged false claims. The rollout is continuing.